http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6001276-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1af8df51ce24ca931ae718fb747f6aa0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-027
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-0225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133723
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-02
filingDate 1997-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99af3f4d7a82b7c79e1c6c167e4c8fc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7aa9a63a1be419c5d77362c3c0bc163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_721f9f8a7f3e5eddd385f3561346476b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a16a7e13272dd90ef29f5350c9da838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de976579a23d849e29860602eee00f42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dea7ef646e8fa8534c18ee0ab32e879
publicationDate 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6001276-A
titleOfInvention Liquid crystal device
abstract A liquid crystal device is constituted by a pair of transparent substrates each having thereon a transparent electrode, and a chiral smectic liquid crystal composition lacking cholesteric phase disposed between the substrates so as to assume at least two optically stable states. At least one of the substrates is provided with an alignment film which comprises a polyimide represented by a recurring unit of formula (I) shown below and has been subjected to a uniaxial aligning treatment. ##STR1## wherein A denotes a tetravalent aliphatic hydrocarbon group free from a planar structure or a tetravalent alicyclic hydrocarbon group, and n is an integer of at least 1. The chiral smectic liquid crystal composition may preferably contain at least one species of fluorine-containing mesomorphic compound comprising a fluorocarbon terminal portion and a hydrocarbon terminal portion connected with a central core and having a smectic phase or a latent smectic phase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016024386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007003709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007002267-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007279541-A1
priorityDate 1996-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0769542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0360521-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5587211-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5552193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5666217-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5325219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5464668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4367924-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0755993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0647695-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5626925-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5250330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5082587-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5129727-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5510159-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02142753-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5419932-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5262082-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5576864-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5320883-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5192596-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5568295-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9322396-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223738064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20449003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226560541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129249756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347925692

Total number of triples: 59.